How to Test Human-Specific Combination Immunotherapies In Vivo
Por um escritor misterioso
Descrição
Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug target mouse models.
Beginners Guide to PBMC Humanized Tumor Models
In vivo gene immunotherapy for cancer
Repurposing Ponatinib as a PD-L1 Inhibitor Revealed by Drug Repurposing Screening and Validation by In Vitro and In Vivo Experiments
Cancers, Free Full-Text
The oncolytic Newcastle disease virus as an effective immunotherapeutic strategy against glioblastoma in: Neurosurgical Focus Volume 50 Issue 2 (2021) Journals
Dendritic cell-based immunotherapy
Inducing CAR-macrophages in the brain for local treatment
Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier, Cancer Cell International
Engineering patient-specific cancer immunotherapies
In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target - ScienceDirect
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
de
por adulto (o preço varia de acordo com o tamanho do grupo)
